HYNIC-iPSMA
Description
HYNIC-iPSMA is a PSMA-targeted ligand for tumor molecular imaging, with a Ki value of 3.11 nM. HYNIC-iPSMA consists of two components: HYNIC (6-hydrazinonicotinamide) and iPSMA (Inhibitor of Prostate-Specific Membrane Antigen). HYNIC acts as a chelating moiety to link radionuclides to the targeting molecule; iPSMA is a specific inhibitor that targets Prostate-Specific Membrane Antigen (PSMA). 68Ga-labeled iPSMA is used for prostate cancer detection via PET imaging, while the further developed 99mTc-EDDA/HYNIC-iPSMA TFA exhibits excellent specificity and sensitivity. HYNIC-iPSMA can be used for the synthesis and research of radionuclide-conjugated drugs (RDC).
Product Information
| Product Name | HYNIC-iPSMA |
| Molecular Weight | 651.67 |
| Formula | C31H37N7O9 |
| CAS Number | 2192215-74-8 |
| Sequence | Hydrazinonicotinyl-Lys(Nal)-Urea-Glu |
| Sequence Shortening | Hydrazinonicotinyl-Lys(Nal)-Urea-Glu |





